“你体检我买单”，部分磷虾油产品套路未改

Core Viewpoint - The article highlights the misleading marketing practices surrounding krill oil supplements, particularly their exaggerated health claims and promises of efficacy, which have led to regulatory scrutiny and corrective actions by some companies [1][10]. Group 1: Misleading Claims and Marketing Practices - Krill oil has been marketed with exaggerated claims, including promises to "cleanse blood vessels" and treat various health conditions, misleading consumers [1][2]. - Common marketing tactics include referencing disease symptoms and making efficacy promises such as "you pay for the test, we pay if there's no change" [2][7]. - Despite some companies making corrections to their advertising, many still use misleading language and imagery that imply health benefits related to serious conditions like heart disease [4][5]. Group 2: Company Responses and Regulatory Actions - Following media scrutiny, several companies, including Fengtai Technology and Ziyi Health, have removed misleading claims from their product listings [2][3]. - Some stores, like Cuixo and Algine Plus, continue to use ambiguous language that suggests therapeutic benefits, despite regulatory guidelines prohibiting such claims [4][5]. - The Chinese government is actively working to regulate misleading advertising in the health supplement sector, with new regulations expected to enhance oversight of online sales and marketing practices [10][11][12]. Group 3: Consumer Protection and Industry Standards - Experts emphasize that while krill oil may have some health benefits, it should not be marketed as a substitute for medication, and consumers should be cautious of exaggerated claims [10]. - The article underscores the importance of compliance with food safety laws, which prohibit health claims for non-medical products, to protect consumers from misleading information [5][6].